Bioceres Crop Solutions Corp. (BIOX)

Market Cap	385.26M
Revenue (ttm)	441.23M
Net Income (ttm)	2.44M
Shares Out	62.85M
EPS (ttm)	0.04
PE Ratio	159.29
Forward PE	15.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	218,648
Open	6.43
Previous Close	6.44
Day's Range	6.12 - 6.45
52-Week Range	5.71 - 14.05
Beta	0.47
Analysts	Strong Buy
Price Target	13.90 (+126.75%)
Earnings Date	Nov 11, 2024

About BIOX

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and se...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2001
• Employees: 389
• Stock Exchange: NASDAQ
• Ticker Symbol: BIOX

Financial Performance

In 2024, Bioceres Crop Solutions's revenue was $464.83 million, an increase of 10.82% compared to the previous year's $419.45 million. Earnings were $3.24 million, a decrease of -82.73%.

Analyst Forecast

According to 5 analysts, the average rating for BIOX stock is "Strong Buy." The 12-month stock price forecast is $13.9, which is an increase of 126.75% from the latest price.

Price Target

$13.9

(126.75% upside)

Analyst Consensus: Strong Buy